Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank93
5Y CAGR+32.2%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

5Y CAGR
+32.2%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$363000.00+98.4%
2024$183000.00+154.8%
2023$-334000.00+68.8%
2022$-1.07M+18.8%
2021$-1.32M-1562.2%
2020$90000.00-89.2%
2019$831000.00+120.5%
2018$-4.06M+93.7%
2017$-64.10M-894.3%
2016$-6.45M-